Mirikizumab Sustained Improvement on Fatigue in Patients With Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study at Week 104

被引：0

作者：

Regueiro, Miguel ^{[1
]}

Fischer, Monika ^{[2
]}

Bossuyt, Peter ^{[3
]}

McGinnis, Kim ^{[4
]}

Gibble, Theresa Hunter ^{[4
]}

Protic, Marijana ^{[4
]}

Panni, Tommaso ^{[4
]}

Hibi, Toshifumi ^{[5
]}

Rubin, David T. ^{[6
]}

机构：

[1] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH USA

[2] Indiana Univ, Indianapolis, IN USA

[3] Imelda GI Clin Res Ctr, Bonheiden, Antwerpen, Belgium

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Kitasato Univ, Minato City, Tokyo, Japan

[6] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1071

引用

页码：S816 / S816

页数：1